Publication Name	World Journal of Hepatology
Manuscript ID	21819
Country	United Kingdom

Received	2015-08-01 08:39
Peer-Review Started	2015-08-06 08:37
To Make the First Decision	2015-09-16 08:59
Return for Revision	2015-09-28 08:37
Revised	2015-10-13 04:06
Second Decision	2016-01-14 17:50
Accepted by Journal Editor-in-Chief	2016-01-16 01:18
Accepted by Company Editor-in-Chief	2016-01-22 16:17
Articles in Press	2016-01-22 16:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-25 11:22
Publish the Manuscript Online	2016-02-15 11:40

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Controversies in the management of primary sclerosing cholangitis
Manuscript Source	Invited Manuscript
All Author List	Jeremy S Nayagam, Stephen P Pereira, John Devlin, Phillip M Harrison and Deepak Joshi
Funding Agency and Grant Number
Corresponding Author	Dr. Deepak Joshi, Institute of Liver Studies, King’s College Hospital, Denmark Hill, London SE5 9RS, United Kingdom. d.joshi@nhs.net
Key Words	Immunoglobulin G4 related sclerosing cholangitis; Cholangiocarcinoma; Primary sclerosing cholangitis; Liver transplantation; Dominant strictures
Core Tip	There have been few advances in therapeutics for primary sclerosing cholangitis (PSC) and there remain areas of controversy in the management of PSC. In this review, we address these controversies, which include the differentiation of PSC from other cholangiopathies, in particular immunoglobulin G4 related sclerosing cho-langitis, the management of dominant biliary strictures, the role of ursodeoxycholic acid, and the timing of liver transplantation.
Publish Date	2016-02-15 11:40
Citation	Nayagam JS, Pereira SP, Devlin J, Harrison PM, Joshi D. Con­troversies in the management of primary sclerosing cholangitis. World J Hepatol 2016; 8(5): 265-272
URL	http://www.wjgnet.com/1948-5182/full/v8/i5/265.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i5.265

Full Article (PDF)	WJH-8-265.pdf
Full Article (Word)	WJH-8-265.doc
Manuscript File	21819-Review.doc
Answering Reviewers	21819-Answering reviewers.pdf
Audio Core Tip	21819-Audio core tip.wma
Conflict-of-Interest Disclosure Form	21819-Conflict-of-interest statement.pdf
Copyright License Agreement	21819-Copyright assignment.pdf
Peer-review Report	21819-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	21819-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	21819-Scientific misconduct check.pdf
Scientific Editor Work List	21819-Scientific editor work list.pdf